Resources
IDEAL® - The Endocrine Society's 95th Annual Meeting and EXPO
Panel 1 References:
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559.
McGill JJ, Shoskes DA, Sabanegh ES Jr. Androgen deficiency in older men: indication, advantages, and pitfalls of testosterone replacement therapy. Cleve Clin J Med. 2012;79(11):797-806.
Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits and risks of testosterone replacement therapy. Int J Endocrinol. 2012;2012:ID625434.
Pinsky MR, Hellstrom WJ. Hypogonadism, ADAM, and hormone replacement. Ther Adv Urol. 2010;2(3):99-104.
Pantalone KM, Faiman C. Male hypogonadism: more than just a low testosterone. Cleve Clin J Med. 2012;79(10):717-725.
PANEL 2 – References
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559.
McGill JJ, Shoskes DA, Sabanegh ES Jr. Androgen deficiency in older men: indication, advantages, and pitfalls of testosterone replacement therapy. Cleve Clin J Med. 2012;79(11):797-806.
Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits and risks of testosterone replacement therapy. Int J Endocrinol. 2012;2012:ID625434.
Pinsky MR, Hellstrom WJ. Hypogonadism, ADAM, and hormone replacement. Ther Adv Urol. 2010;2(3):99-104.
Pantalone KM, Faiman C. Male hypogonadism: more than just a low testosterone. Cleve Clin J Med. 2012;79(10):717-725.
PANEL 3 – References
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559.
McGill JJ, Shoskes DA, Sabanegh ES Jr. Androgen deficiency in older men: indication, advantages, and pitfalls of testosterone replacement therapy. Cleve Clin J Med. 2012;79(11):797-806.
Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits and risks of testosterone replacement therapy. Int J Endocrinol. 2012;2012:ID625434.
Pinsky MR, Hellstrom WJ. Hypogonadism, ADAM, and hormone replacement. Ther Adv Urol. 2010;2(3):99-104.
Pantalone KM, Faiman C. Male hypogonadism: more than just a low testosterone. Cleve Clin J Med. 2012;79(10):717-725.
PANEL 4 – References
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559.
McGill JJ, Shoskes DA, Sabanegh ES Jr. Androgen deficiency in older men: indication, advantages, and pitfalls of testosterone replacement therapy. Cleve Clin J Med. 2012;79(11):797-806.
Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits and risks of testosterone replacement therapy. Int J Endocrinol. 2012;2012:ID625434.
Pinsky MR, Hellstrom WJ. Hypogonadism, ADAM, and hormone replacement. Ther Adv Urol. 2010;2(3):99-104.
Pantalone KM, Faiman C. Male hypogonadism: more than just a low testosterone. Cleve Clin J Med. 2012;79(10):717-725.
PANEL 5 – References
Cunningham GR, Toma SM. Clinical review: Why is androgen replacement in males controversial? J Clin Endocrinol Metab. 2011;96:38-52.
Practice Committee of the American Society for Reproductive Medicine; Society for Male Reproduction and Urology. Androgen deficiency in the aging male. Fertil Steril. 2008; 90(suppl 5):S83-S87.
PANEL 6 – References
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559.
McGill JJ, Shoskes DA, Sabanegh ES Jr. Androgen deficiency in older men: indication, advantages, and pitfalls of testosterone replacement therapy. Cleve Clin J Med. 2012;79(11):797-806.
Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits and risks of testosterone replacement therapy. Int J Endocrinol. 2012;2012:ID625434.
Pinsky MR, Hellstrom WJ. Hypogonadism, ADAM, and hormone replacement. Ther Adv Urol. 2010;2(3):99-104.
Pantalone KM, Faiman C. Male hypogonadism: more than just a low testosterone. Cleve Clin J Med. 2012;79(10):717-725.
PANEL 7 – References
Bebb RA. Testosterone deficiency: practical guidelines for diagnosis and treatment. BC Med J. 2011;53:474-479.
Bhasin S, Cunningham GR, Hayes FJ, et al; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559.
Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl. 2003;24:299-311.
Fernández-Balsells MM, Murad MH, Lane M, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010;95:2560-2575.
Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol. 2008;159:507-514.